Cite
HARVARD Citation
Young, R. et al. (n.d.). 3434 A UK national phase I/II clinical trial of a MEK1/2 inhibitor combined with highly active anti-retroviral therapy for HIV-associated Kaposi's sarcoma. European journal of cancer. pp. S699-. [Online].